When you think of the shingles vaccine, you probably think of preventing a painful, blistering skin rash. However, landmark clinical research reveals that getting vaccinated protects more than just your skin—it actively safeguards your cardiovascular system.
The Hidden Link Between Shingles and Heart Attacks
The varicella-zoster virus (the virus responsible for chickenpox and shingles) does not stay confined to the surface of your skin. It can invade the arterial walls, triggering acute vascular inflammation and causing local blood vessel damage (Parameswaran et al., 2023). This disruption can destabilize existing arterial plaques, dramatically increasing the risk of blood clots.
Medical data shows that a recent shingles infection elevates a patient’s risk of experiencing a stroke or a myocardial infarction (heart attack) by up to 35% within the first 30 days post-infection (Parameswaran et al., 2023).
How Shingrix Lowers Cardiovascular Risk
By preventing the viral reactivation that triggers systemic inflammation, the Shingrix vaccine acts as a shield for your heart. Recent clinical studies found that:
- Patients who received the recombinant zoster vaccine (Shingrix) were 18% less likely to suffer a heart attack compared to unvaccinated peers (Parameswaran et al., 2023).
- In high-risk demographics, such as individuals living with diabetes, shingles vaccination was associated with a 24% lower risk of major adverse cardiovascular events (MACE), including coronary artery disease and acute stroke (Kornelius et al., 2025).
If you are over the age of 50, the Shingrix vaccine isn’t just a defense against a painful rash—it is a critical addition to your heart disease prevention strategy.
Your Direct Path to Prevention
Don’t wait for a painful outbreak to protect your cardiovascular health. At MyDoctor, we make preventive care seamless. Book a consultation with MyDoctor today to check your eligibility, review your vaccine schedule, and secure your Shingrix doses.